Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.34 USD | -2.13% | +0.68% | -5.02% |
Mar. 13 | Top Premarket Decliners | MT |
Mar. 12 | JPMorgan Adjusts Price Target on iTeos Therapeutics to $27 From $29, Maintains Overweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.02% | 379M | |
-0.75% | 104B | |
+3.99% | 97.42B | |
-0.03% | 22.2B | |
-16.52% | 21.23B | |
-10.39% | 18.33B | |
-42.33% | 16.35B | |
-17.92% | 15.06B | |
+5.78% | 13.98B | |
+28.41% | 11.66B |
- Stock Market
- Equities
- ITOS Stock
- News iTeos Therapeutics, Inc.
- HC Wainwright Adjusts iTeos Therapeutics' Price Target to $54 from $37, Keeps Buy Rating